FDA advisory committee recommends approval of a booster shot of the Johnson & ...
BREAKING NEWS: FDA advisory committee recommends approval of a booster shot of the Johnson & Johnson COVID-19 vaccine in ALL adults aged 18 and older two months after the first dose The FDA's advisory committee unanimously voted to recommend approval of Covid booster shots of Johnson & Johnson's vaccine on Friday The booster shot will be available to all adults aged 18 and older and given two months after the first dose It comes a day after booster doses of the Moderna vaccines were recommended for approval but only for at-risk groups such as those aged 65 and older Last month, J&J released data showing a booster dose of its COVID-19 was 94% protective against severe disease compared to 70% for one dose
View
comments
An advisory committee for the U.S. Food and Drug Administration (FDA) has unanimously voted to recommend approval of booster doses of Johnson & Johnson's COVID-19 vaccine.
The boosters have been approved for all adults aged 18 and older and will be given two months after the first dose.
It comes exactly one day after the Vaccines and Related Biological Products Advisory Committee (VRBPAC) recommended approval of boosters for the Moderna vaccine.
